SCHEMBL4481795

SCHEMBL4481795

COc1ccc(-c2cc(=O)c(-c3c(C)[nH]c(C)c(Cl)c3=O)c[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 7/20 0.43
HPGD P15428 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
BRD4 O60885 1/20 0.39
SLC2A1 P11166 1/20 0.39
THRB P10828 1/20 0.39
PKM P14618 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAP2K1 Q02750 1/20 0.38
IDO1 P14902 2/20 0.38
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
GSTP1 P09211 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478743 0.88 SLC2A1 (0.42) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
SCHEMBL4474681 0.87 SLC2A1 (0.37) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
SCHEMBL4490716 0.86 SCN10A (0.37) SLC2A1
Hydrochloric Acid SCHEMBL4489667 0.85 SCN10A (0.36) KDM4ESLC2A1
SCHEMBL4475367 0.85 ADORA2A (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
SCHEMBL4480202 0.85 SCN9A (0.36) KDM4ESMN1; SMN2NPC1RAB9AMAPT
SCHEMBL3392240 0.83 PRKAB2 (0.36) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL4482112 0.83 L3MBTL1 (0.39) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT
SCHEMBL4483594 0.82 MEN1 (0.31) NPC1RAB9AMEN1KMT2ABRD4
SCHEMBL4490544 0.81 BRD4 (0.39) NPC1RAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed
EP-1858876-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2007-11-28 EP disclosed
WO-2006094799-A2 PYRIDINONE DERIVATIVES AGAINST MALARIA GLAXO GROUP LIMITED (GB) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP ALDH1A1 287/4885KDM4E 1311/4885HPGD 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.